에너지균형에 미치는 흰지방조직 내 혈관의 역할

참고문헌 (169)

1. Flegal KM, "Prevalence and trends in obesity among US adults, 1999-2008", JAMA, 303, pp.235~241 (2008)
2. Wang Y, "Worldwide trends in childhood overweight and obesity", International journal of pediatric obesity: IJPO: an official journal of the International Association for the Study of Obesity, 1, pp.11~25 (2006)
3. "The 2010 Korean National Health and Nutrition Examination Survey", ~
4. Wright SM, "Obesity in 2010: The future of obesity medicine: Where do we go from here", Nature Reviews Endocrinology, 7, pp.69~71 (2011)
5. Seeley RJ, "Monitoring of stored and available fuel by the CNS: implications for obesity", Nat Rev Neurosci, 4, pp.901~909 (2003)
6. Flier JS, "Obesity wars: molecular progress confronts an expanding epidemic", Cell, 116, pp.337~350 (2004)
7. Johansson K, "Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis", Obes Rev, 10, pp.564~575 (2009)
8. Myers MG, "Mechanisms of leptin action and leptin resistance", Annu Rev Physiol, 70, pp.537~556 (2008)
9. 김동훈, "Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body Weight", DIABETES, 59(4), pp.907~915, AMER DIABETES ASSOC
10. Kolonin MG, "Reversal of obesity by targeted ablation of adipose tissue", Nat Med, 10, pp.625~632 (2004)
11. Brakenhielm E, "Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice", Circ Res, 94, pp.1579~1588 (2004)
12. Rupnick MA, "Adipose tissue mass can be regulated through the vasculature", Proc Natl Acad Sci U S A, 99, pp.10730~10735 (2002)
13. Morton GJ, "Central nervous system control of food intake and body weight", Nature, 443, pp.289~295 (2006)
14. Schwartz MW, "Diabetes, obesity, and the brain", Science, 307, pp.375~379 (2005)
15. Clark JT, "Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats", Endocrinology, 115, pp.427~429 (1984)
16. Luquet S, "NPY", AgRP neurons are essential for feeding in adult mice but can be ablated in neonates, 2005, pp.310, 683~685
17. Gropp E, "Agouti-related peptide-expressing neurons are mandatory for feeding", Nat Neurosci, 8, pp.1289~1291 (2005)
18. Krude H, "Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans", Nature Genetics, 19, pp.155~157 (1998)
19. Ernst MB, "Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity", J Neurosci, 29, pp.11582~11593 (2009)
20. Cowley MA, "Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus", Nature, 411, pp.480~484 (2001)
21. Roseberry AG, "Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob", ob mice, 2004, pp.41, 711~722
22. Benoit SC, "Insulin and leptin as adiposity signals", Recent Progress in Hormone Research, 59, pp.267~285 (2004)
23. Woods SC, "Regulation of food intake through hypothalamic signaling networks involving mTOR", Annu Rev Nutr, 28, pp.295~311 (2008)
24. Berthoud HR, "The brain, appetite, and obesity", Annu Rev Psychol, 59, pp.55~92 (2008)
25. Woods SC, "The control of food intake: behavioral versus molecular perspectives", Cell Metab, 9, pp.489~498 (2009)
26. le Roux CW, "Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy", J Clin Endocrinol Metab, 90, pp.4521~4524 (2005)
27. Chelikani PK, "Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats", Endocrinology, 146, pp.879~888 (2005)
28. Mayer J, "Glucostatic mechanism of regulation of food intake", N Engl J Med, 249, pp.13~16 (1953)
29. Mayer J, "Regulation of energy intake and the body weight: The glucostatic theory and the lipostatic hypothesis", Ann NY Acad Sci, 63, pp.15~43 (1955)
30. Miselis RR, "Feeding induced by intracerebroventricular 2 deoxy D glucose in the rat", American Journal of Physiology, 229, pp.1438~1447 (1975)
31. Katafuchi T, "Single neuron activity in the rat lateral hypothalamus during 2-deoxy-D-glucose induced and natural feeding behavior", Brain Research, 359, pp.1~9 (1985)
32. Oomura Y, "Glucose and osmosensitive neurones of the rat hypothalamus", Nature, 222, pp.282~284 (1969)
33. Levin BE, "Brain glucose sensing and body energy homeostasis: role in obesity and diabetes", Am J Physiol, 276, pp.R1223~R1231 (1999)
34. Dunn-Meynell AA, "Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain", Brain Res, 814, pp.41~54 (1998)
35. Ashcroft FM, "Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells", Nature, 312, pp.446~448 (1984)
36. Pocai A, "Hypothalamic K(ATP) channels control hepatic glucose production", Nature, 434, pp.1026~1031 (2005)
37. Obici S, "Central administration of oleic acid inhibits glucose production and food intake", Diabetes, 51, pp.271~275 (2002)
38. Loftus TM, "Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors", Science, 288, pp.2379~2381 (2000)
39. Obici S, "Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production", Nat Med, 9, pp.756~761 (2003)
40. He W, "Molecular disruption of hypothalamic nutrient sensing induces obesity", Nat Neurosci, 9, pp.227~233 (2006)
41. Wortman MD, "C75 inhibits food intake by increasing CNS glucose metabolism", Nat Med, 9, pp.483~485 (2003)
42. Kumar MV, "Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice", Proc Natl Acad Sci U S A, 99, pp.1921~1925 (2002)
43. Shimokawa T, "Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides", Proc Natl Acad Sci U S A, 99, pp.66~71 (2002)
44. Proulx K, "Fatty acid synthase inhibitors modulate energy balance via mammalian target of rapamycin complex 1 signaling in the central nervous system", Diabetes, 57, pp.3231~3238 (2008)
45. 김은경, "C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase", JOURNAL OF BIOLOGICAL CHEMISTRY, 279(19), pp.19970~19976, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
46. Elmquist JK, "Distributions of leptin receptor mRNA isoforms in the rat brain", J Comp Neurol, 395, pp.535~547 (1998)
47. Bjorbaek C, "Divergent signaling capacities of the long and short isoforms of the leptin receptor", J Biol Chem, 272, pp.32686~32695 (1997)
48. Munzberg H, "Region-specific leptin resistance within the hypothalamus of diet-induced obese mice", Endocrinology, 145, pp.4880~4889 (2004)
49. Williams DL, "Hindbrain leptin receptor stimulation enhances the anorexic response to cholecystokinin", Am J Physiol Regul Integr Comp Physiol, 297, pp.R1238~R1246 (2009)
50. Morton GJ, "Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons", Cell Metab, 2, pp.411~420 (2005)
51. Kelley AE, "Neural systems recruited by drug- and food-related cues: studies of gene activation in corticolimbic regions", Physiol Behav, 86, pp.11~14 (2005)
52. Kelley AE, "The neuroscience of natural rewards: relevance to addictive drugs", J Neurosci, 22, pp.3306~3311 (2002)
53. Niswender KD, "Intracellular signalling. Key enzyme in leptin-induced anorexia", Nature, 413, pp.794~795 (2001)
54. Zhao AZ, "A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding", Nat Neurosci, 5, pp.727~728 (2002)
55. Kim MS, "Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis", NATURE NEUROSCIENCE, 9(7), pp.901~906
56. Cota D, "Hypothalamic mTOR signaling regulates food intake", Science, 312, pp.927~930 (2006)
57. Howard JK, "Attenuation of leptin and insulin signaling by SOCS proteins", Trends Endocrinol Metab, 17, pp.365~371 (2006)
58. Bjorbaek C, "The role of SOCS-3 in leptin signaling and leptin resistance", J Biol Chem, 274, pp.30059~30065 (1997)
59. Bjorbaek C, "Identification of SOCS-3 as a potential mediator of central leptin resistance", Mol Cell, 1, pp.619~625 (1998)
60. Bence KK, "Neuronal PTP1B regulates body weight, adiposity and leptin action", Nat Med, 12, pp.917~924 (2006)
61. Zhang XQ, "Hypothalamic IKK beta", NF-kappa B and ER stress link overnutrition to energy imbalance and obesity, 2008, pp.135, 61~73
62. Niswender KD, "Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia", Diabetes, 52, pp.227~231 (2003)
63. Manning BD, "AKT", PKB signaling: navigating downstream, 2007, pp.129, 1261~1274
64. Bruning JC, "Role of brain insulin receptor in control of body weight and reproduction", Science, 289, pp.2122~2125 (2000)
65. Burks DJ, "IRS-2 pathways integrate female reproduction and energy homeostasis", Nature, 407, pp.377~382 (2000)
66. Xu AW, "PI3K integrates the action of insulin and leptin on hypothalamic neurons", J Clin Invest, 115, pp.951~958 (2005)
67. Hill JW, "Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice", J Clin Invest, 118, pp.1796~1805 (2008)
68. Xu Y, "PI3K signaling in the ventromedial hypothalamic nucleus is required for normal energy homeostasis", Cell Metab, 12, pp.88~95 (2010)
69. Tang ED, "Negative regulation of the forkhead transcription factor FKHR by Akt", J Biol Chem, 274, pp.16741~16746 (1999)
70. Aoki M, "Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins", Proc Natl Acad Sci U S A, 101, pp.13613~13617 (2004)
71. Matsuzaki H, "Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation", Proc Natl Acad Sci U S A, 100, pp.11285~11290 (2003)
72. Posey KA, "Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet", Am J Physiol Endocrinol Metab, 296, pp.E1003~E1012 (2009)
73. Benoit SC, "Palmitic acid mediates hypothalamic insulin resistance by altering PKC-ɵ subcellular localization in rodents", Journal of Clinical Investigation, 119, pp.2577~2589 (2009)
74. Ozcan L, "Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance", Cell Metabolism, 9, pp.35~51 (2009)
75. Kleinridders A, "MyD88 Signaling in the CNS Is Required for Development of Fatty Acid-Induced Leptin Resistance and Diet-Induced Obesity", Cell Metabolism, 10, pp.249~259 (2009)
76. Wullschleger S, "TOR signaling in growth and metabolism", Cell, 124, pp.471~484 (2006)
77. Cota D, "The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity", J Neurosci, 28, pp.7202~7208 (2008)
78. Blouet C, "Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis", Cell Metab, 8, pp.459~467 (2008)
79. Mori H, "Critical role for hypothalamic mTOR activity in energy balance", Cell Metab, 9, pp.362~374 (2009)
80. Lopez M, "Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin", Cell Metab, 7, pp.389~399 (2008)
81. Minokoshi Y, "AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus", Nature, 428, pp.569~574 (2004)
82. Lage R, "AMPK: a metabolic gauge regulating whole-body energy homeostasis", Trends Mol Med, 14, pp.539~549 (2008)
83. Kahn BB, "AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism", Cell Metab, 1, pp.15~25 (2005)
84. Sanders MJ, "Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade", Biochemical Journal, 403, pp.139~148 (2007)
85. Qi J, "Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue", EMBO Journal, 27, pp.1537~1548 (2008)
86. Kim MS, "Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase", Nat Med, 10, pp.727~733 (2004)
87. 정현주, "Acute Effects of Glucagon-Like Peptide-1 on Hypothalamic Neuropeptide and AMP Activated Kinase Expression in Fasted Rats", ENDOCRINE JOURNAL, 55, pp.867~874, JAPAN ENDOCRINE SOC
88. Steinberg GR, "Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin- resistant obese mice", Endocrinology, 147, pp.3906~3914 (2006)
89. Stoppa GR, "Intracerebroventricular injection of citrate inhibits hypothalamic AMPK and modulates feeding behavior and peripheral insulin signaling", J Endocrinol, 198, pp.157~168 (2008)
90. Ropelle ER, "A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss", Diabetes, 57, pp.594~605 (2008)
91. Andersson U, "AMP-activated Protein Kinase Plays a Role in the Control of Food Intake", Journal of Biological Chemistry, 279, pp.12005~12008 (2004)
92. Kola B, "Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase", J Biol Chem, 280, pp.25196~25201 (2005)
93. Kubota N, "Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake", Cell Metab, 6, pp.55~68 (2007)
94. Shimizu H, "Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats", Endocrinology, 149, pp.4544~4553 (2008)
95. Vazquez MJ, "Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion", Endocrinology, 149, pp.4534~4543 (2008)
96. Cota D, "Leptin in energy balance and reward: two faces of the same coin", Neuron, 51, pp.678~680 (2006)
97. Um SH, "Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1", Cell Metab, 3, pp.393~402 (2006)
98. Rolls ET, "Reward-spatial view representations and learning in the primate hippocampus", J Neurosci, 25, pp.6167~6174 (2005)
99. Kringelbach ML, "Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness", Cereb Cortex, 13, pp.1064~1071 (2003)
100. Pritchard TC, "Satiety-responsive neurons in the medial orbitofrontal cortex of the macaque", Behav Neurosci, 122, pp.174~182 (2008)
101. Robinson TE, "Addiction", Annu Rev Psychol, 54, pp.25~53 (2003)
102. Commerford SR, "Fat oxidation, lipolysis, and free fatty acid cycling in obesity-prone and obesity-resistant rats", Am J Physiol Endocrinol Metab, 279, pp.E875~E885 (2000)
103. Wang YH, "Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats", Am J Physiol, 273, pp.R833~R837 (1997)
104. Bado A, "The stomach is a source of leptin", Nature, 394, pp.790~793 (1998)
105. Moran TH, "Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin", Am J Physiol Regul Integr Comp Physiol, 272, pp.R1245~R1251 (1997)
106. Morton GJ, "Leptin action in the forebrain regulates the hindbrain response to satiety signals", J Clin Invest, 115, pp.703~710 (2005)
107. Kojima M, "Ghrelin is a growth-hormone-releasing acylated peptide from stomach", Nature, 402, pp.656~660 (1999)
108. Mayer J, "Regulation of food intake and obesity", Science, 156, pp.328~337 (1967)
109. Tschop M, "Ghrelin induces adiposity in rodents", Nature, 407, pp.908~913 (2000)
110. Nakazato M, "A role for ghrelin in the central regulation of feeding", Nature, 409, pp.194~198 (2001)
111. Cummings DE, "A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans", Diabetes, 50, pp.1714~1719 (2001)
112. Date Y, "The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats", Gastroenterology, 123, pp.1120~1128 (2002)
113. Burdyga G, "Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance", Am J Physiol Gastrointest Liver Physiol, 290, pp.G1289~G1297 (2006)
114. Le Roux CW, "Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy", Journal of Clinical Endocrinology and Metabolism, 90, pp.4521~4524 (2005)
115. Eberlein GA, "A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36)", Peptides, 10, pp.797~803 (1989)
116. Batterham RL, "Gut hormone PYY3-36 physiologically inhibits food intake", Nature, 418, pp.650~654 (2002)
117. Chelikani PK, "Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats", Am J Physiol Regul Integr Comp Physiol, 290, pp.R298~R305 (2006)
118. Larhammar D, "Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide", Regul Pept, 65, pp.165~174 (1996)
119. Riediger T, "Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression", Neuroendocrinology, 79, pp.317~326 (2004)
120. Koda S, "The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats", Endocrinology, 146, pp.2369~2375 (2005)
121. Batterham RL, "Critical role for peptide YY in protein-mediated satiation and body-weight regulation", Cell Metab, 4, pp.223~233 (2006)
122. D'Alessio DA, "Enteral enhancement of glucose disposition by both insulin-dependent and insulin- independent processes. A physiological role of glucagon-like peptide I", Diabetes, 44, pp.1433~1437 (1995)
123. after subcutaneous injection in healthy volunteers. Dose-response-relationships, "Diabetologia", 1995, 720~725
124. Schirra J, "The physiological role of GLP-1 in human: incretin, ileal brake or more", Regul Pept, 128, pp.109~115 (2005)
125. Gutzwiller JP, "Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2", Am J Physiol, 276, pp.R1541~R1544 (1999)
126. Tang-Christensen M, "Glucagon-like peptide containing pathways in the regulation of feeding behaviour", Int J Obes Relat Metab Disord, 25(5), pp.S42~S47 (2001)
127. Nakabayashi H, "Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1", Am J Physiol, 271, pp.E808~E813 (1996)
128. Kakei M, "Glucagon- like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons", Auton Neurosci, 102, pp.39~44 (2002)
129. Nakagawa A, "Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells", Auton Neurosci, 110, pp.36~43 (2004)
130. Merchenthaler I, "Distribution of pre- pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system", J Comp Neurol, 403, pp.261~280 (1999)
131. Yamamoto H, "Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites", J Neurosci, 23, pp.2939~2946 (2003)
132. Vahl TP, "Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats", Endocrinology, 148, pp.4965~4973 (2007)
133. Kim DH, "The effects of GLP-1 infusion in the hepatic portal region on food intake", Regul Pept, 155, pp.110~114 (2009)
134. Ruttimann EB, "Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms", Endocrinology, 150, pp.1174~1181 (2009)
135. Woods SC, "Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons", Nature, 282, pp.503~505 (1979)
136. Berthoud HR, "Functional and chemical anatomy of the afferent vagal system", Auton Neurosci, 85, pp.1~17 (2000)
137. Kojima M, "Ghrelin is a growth-hormone-releasing acylated peptide from stomach", Nature, 402, pp.656~660 (1999)
138. Porte D, Jr., "Regulation of food intake and body weight in insulin", Diabetologia, 20, pp.274~280 (1981)
139. Zhang Y, "Positional cloning of the mouse obese gene and its human homologue", Nature, 372, pp.425~432 (1994)
140. Schwartz MW, "Central nervous system control of food intake", Nature, 404, pp.661~671 (2000)
141. Kimura KD, "daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans", Science, 277, pp.942~946 (1997)
142. Garofalo RS, "Genetic analysis of insulin signaling in Drosophila", Trends Endocrinol Metab, 13, pp.156~162 (2002)
143. Doyon C, "Molecular evolution of leptin", Gen Comp Endocrinol, 124, pp.188~198 (2001)
144. Farooqi IS, "Effects of recombinant leptin therapy in a child with congenital leptin deficiency", N Engl J Med, 341, pp.879~884 (1999)
145. Obici S, "Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats", Nat Neurosci, 5, pp.566~572 (2002)
146. Plum L, "Central insulin action in energy and glucose homeostasis", Journal of Clinical Investigation, 116, pp.1761~1766 (2006)
147. Woods SC, "Food intake and the regulation of body weight", Annu Rev Psychol, 51, pp.255~277 (2000)
148. Niswender KD, "Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities", Front Neuroendocrinol, 24, pp.1~10 (2003)
149. Plum L, "Central insulin action in energy and glucose homeostasis", J Clin Invest, 116, pp.1761~1766 (2006)
150. Münzberg H, "Molecular and anatomical determinants of central leptin resistance", Nature Neuroscience, 8, pp.566~570 (2005)
151. Xu AW, "Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding", Endocrinology, 148, pp.72~80 (2007)
152. Bates SH, "STAT3 signalling is required for leptin regulation of energy balance but not reproduction", Nature, 421, pp.856~859 (2003)
153. Myers MG, Jr., "Obesity and leptin resistance: distinguishing cause from effect", Trends Endocrinol Metab, 21, pp.643~651 (2010)
154. Halberg N, "The Adipocyte as an Endocrine Cell", Endocrinology and Metabolism Clinics of North America, 37, pp.753~768 (2008)
155. Spiegelman BM, "Obesity and the regulation of energy balance", Cell, 104, pp.531~543 (2001)
156. Daquinag AC, "Vascular targeting of adipose tissue as an anti-obesity approach", Trends Pharmacol Sci, 32, pp.300~307 (2011)
157. Christiaens V, "Angiogenesis and development of adipose tissue", Molecular and Cellular Endocrinology, 318, pp.2~9 (2010)
158. Cao Y, "Angiogenesis modulates adipogenesis and obesity", J Clin Invest, 117, pp.2362~2368 (2007)
159. Fukumura D, "Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis", Circ Res, 93, pp.e88~e97 (2003)
160. Nishimura S, "Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels", Diabetes, 56, pp.1517~1526 (2007)
161. Cho CH, "Angiogenic role of LYVE-1-positive macrophages in adipose tissue", Circulation Research, 100, pp.e47~e57 (2007)
162. Lijnen HR, "Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity", Obesity, 18, pp.2241~2246 (2010)
163. Folkman J, "Angiogenesis: an organizing principle for drug discovery", Nat Rev Drug Discov, 6, pp.273~286 (2007)
164. Folkman J, "Endogenous angiogenesis inhibitors", APMIS, 112, pp.496~507 (2004)
165. Moitra J, "Life without white fat: a transgenic mouse", Genes Dev, 12, pp.3168~3181 (1998)
166. Pajvani UB, "Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy", Nat Med, 11, pp.797~803 (2005)
167. Crandall DL, "A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives", Microcirculation, 4, pp.211~232 (1997)
168. Fulton S, "Modulation of brain reward circuitry by leptin", Science, 287, pp.125~128 (2000)
169. Levin BE, "Neuronal glucosensing: What do we know after 50 years", Diabetes, 53, pp.2521~2528 (2004)

관련 논문AI추천